CN Patent

CN114206348A — 可注射曲安奈德配制品

Assigned to Clearside Biomedical Inc · Expires 2022-03-18 · 4y expired

What this patent protects

本公开文本涉及醋酸曲安奈德的药物混悬液、生产此类混悬液的方法和使用此类混悬液的方法。本公开文本的药物混悬液是稳定的并且适合经由30号微针通过脉络膜上注射施用。

USPTO Abstract

本公开文本涉及醋酸曲安奈德的药物混悬液、生产此类混悬液的方法和使用此类混悬液的方法。本公开文本的药物混悬液是稳定的并且适合经由30号微针通过脉络膜上注射施用。

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: CN114206348A
Jurisdiction: CN
Classification: —
Expires: 2022-03-18
Drug substance claim: No
Drug product claim: No
Assignee: Clearside Biomedical Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.